• Cyclic di-GMP for Reliable Biofilm and Immunity Assays

  2026-05-15

  This article guides biomedical researchers through experimental challenges in biofilm formation and immune modulation research, illustrating how Cyclic di-GMP (SKU B7839) from APExBIO delivers reproducible, high-purity results. Drawing on current literature and validated workflows, we address protocol optimization, data interpretation, and vendor selection for advanced cell-based assays.

• PSPro Enables Single-Cell-Type Spatial Proteome Profiling in

  2026-05-15

  Mao et al. introduce PSPro, a proximity labeling-based workflow that achieves comprehensive, cell-type-resolved spatial proteomics from intact tissue slices. This method optimizes antibody-guided biotinylation and affinity purification to map proteomic heterogeneity at sub-micrometer resolution, offering new insights into tissue complexity and disease microenvironments.

• Dual “Engage & Evasion” Enhances EV Therapy via MPS Escape

  2026-05-14

  Liu et al. introduce a two-step 'Engage & Evasion' strategy to overcome rapid mononuclear phagocyte system (MPS) clearance of extracellular vesicles (EVs), improving their retention and organ targeting in ischemic disease models. This approach leverages sequential MPS saturation and CD47-enriched EV delivery to maximize therapeutic efficacy in tissue regeneration.

• N6-Methyl-dATP: Driving Epigenetic Assays for DNA Fidelity

  2026-05-14

  N6-Methyl-dATP (SKU B8093) redefines methylation modification research by enabling precise interrogation of DNA replication fidelity and epigenetic regulation. Its robust integration into advanced workflows delivers reproducible results in genomic stability and leukemia research, with APExBIO as the reliable supplier for high-purity standards.

• METTL16-SENP3-LTF Axis Drives Ferroptosis Resistance in HCC

  2026-05-13

  Wang et al. identify the METTL16-SENP3-LTF pathway as a critical regulator of ferroptosis resistance and tumorigenesis in hepatocellular carcinoma (HCC). This study provides molecular insight into how epitranscriptomic and iron metabolism regulators contribute to HCC progression and suggests new research directions for modulating ferroptosis in cancer therapy.

• RP3-340N1.2 Knockdown Destabilizes IL-6 in NSCLC Progression

  2026-05-13

  The referenced study identifies the long non-coding RNA RP3-340N1.2 as a key stabilizer of IL-6 mRNA in non-small cell lung cancer (NSCLC). Knockdown of RP3-340N1.2 enhances IL-6 mRNA degradation, reducing tumor cell proliferation and migration, and offers a mechanistic target for transcriptional regulation research.

• ddATP in DNA Damage Amplification: Beyond Chain Termination

  2026-05-12

  Explore how ddATP (2',3'-dideoxyadenosine triphosphate) advances DNA replication research by modulating short-scale break-induced replication and damage amplification, offering insight into oocyte genome stability. This article reveals practical assay strategies and mechanistic depth not found in standard ddATP workflows.

• Ertapenem Sodium Salt: Optimized Workflows for Resistance Pr

  2026-05-12

  Ertapenem (sodium salt) enables precise, reproducible profiling of Gram-positive and Gram-negative bacterial resistance, supporting advanced molecular epidemiology. This guide distills best practices, troubleshooting insights, and reference-driven innovations for robust laboratory workflows.

• LY2886721: BACE Inhibitor Workflows for Alzheimer’s Research

  2026-05-11

  LY2886721 enables precise, nanomolar-range inhibition of BACE1, supporting advanced workflows in amyloid beta reduction without compromising synaptic integrity. Its robust data-backed performance and oral bioavailability make it a benchmark tool for Alzheimer's disease research models.

• Metoprolol as a Selective Beta1-Adrenoceptor Antagonist in A

  2026-05-11

  Metoprolol, a selective beta1-adrenoceptor antagonist from APExBIO, is redefining experimental workflows in cardiovascular, inflammation, and cancer biology research. This detailed guide explores practical protocols, troubleshooting, and applications that harness Metoprolol’s unique pharmacological profile for reproducible, high-impact results.

• PCMT1 Identified as a Driver of Ovarian Cancer Metastasis

  2026-05-10

  Zhang et al. used a genome-wide CRISPR/Cas9 knockout screen to identify PCMT1 as a critical regulator of anoikis resistance and metastasis in ovarian cancer. Their findings highlight PCMT1-mediated modulation of the ECM and integrin-FAK-Src signaling, providing new insights into metastatic mechanisms and therapeutic targets.

• Disulfiram: Dopamine β-Hydroxylase Inhibitor in Cancer Resea

  2026-05-09

  Disulfiram’s role as a dopamine β-hydroxylase inhibitor now extends to precision cancer research, offering robust proteasome inhibition and apoptotic cancer cell death induction in validated models. Discover optimized workflows, troubleshooting strategies, and the latest evidence from synthetic lethality studies that maximize Disulfiram’s translational impact.

• Tamoxifen: Selective Estrogen Receptor Modulator in Gene Edi

  2026-05-08

  Tamoxifen is a selective estrogen receptor modulator that uniquely enables CreER-mediated gene knockout, breast cancer research, and kinase pathway interrogation. This guide details advanced protocols, troubleshooting, and the transformative impact of a reference study on B cell lipid metabolism for optimizing tamoxifen-based workflows.

• S Tag Peptide: Technical Guide for Recombinant Protein Detec

  2026-05-08

  S Tag Peptide (SKU A6007) addresses challenges in recombinant protein detection, purification, and solubility enhancement by providing a reliable, highly soluble fusion tag compatible with anti-S-Tag antibody assays. It is suitable for workflows requiring aqueous solubility and affinity-based detection, but not for protocols involving ethanol or long-term solution storage. Researchers should follow recommended handling and compatibility guidelines to avoid common technical pitfalls.

• Thiothixene: Typical Antipsychotic Agent in Macrophage Effer

  2026-05-07

  Thiothixene stands out by bridging psychiatric research and immunology, uniquely enhancing in vitro macrophage efferocytosis via vitamin A signaling and arginase 1 upregulation. This article details protocol parameters, troubleshooting strategies, and advanced applications, empowering reliable and reproducible workflows using APExBIO’s high-quality Thiothixene.

3711 records 16/248 page Previous Next First page 上5页 1617181920 下5页 Last page